Heat Biologics Stock Fundamentals
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Heat Biologics' long-term financial health and intrinsic value.
Heat |
Heat Biologics Company Current Valuation Analysis
Heat Biologics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Heat Biologics Current Valuation | (34.74 M) |
Most of Heat Biologics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Heat Biologics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Heat Biologics has a Current Valuation of (34.74 Million). This is 100.24% lower than that of the Healthcare sector and 100.75% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 100.21% higher than that of the company.
Heat Biologics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Heat Biologics's current stock value. Our valuation model uses many indicators to compare Heat Biologics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Heat Biologics competition to find correlations between indicators driving Heat Biologics's intrinsic value. More Info.Heat Biologics is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Heat Biologics' earnings, one of the primary drivers of an investment's value.Heat Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heat Biologics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heat Biologics could also be used in its relative valuation, which is a method of valuing Heat Biologics by comparing valuation metrics of similar companies.Heat Biologics is currently under evaluation in current valuation category among its peers.
Heat Fundamentals
| Return On Equity | -31.12 | |||
| Return On Asset | -17.1 | |||
| Current Valuation | (34.74 M) | |||
| Shares Outstanding | 25.4 M | |||
| Shares Owned By Insiders | 5.20 % | |||
| Shares Owned By Institutions | 10.77 % | |||
| Number Of Shares Shorted | 1.17 M | |||
| Price To Earning | (1.29) X | |||
| Price To Book | 0.48 X | |||
| Price To Sales | 28.62 X | |||
| Revenue | 2.11 M | |||
| Gross Profit | (16.71 M) | |||
| EBITDA | (32.93 M) | |||
| Net Income | (35.07 M) | |||
| Cash And Equivalents | 96.38 M | |||
| Cash Per Share | 3.76 X | |||
| Total Debt | 1.93 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 21.04 X | |||
| Book Value Per Share | 4.97 X | |||
| Cash Flow From Operations | (38.13 M) | |||
| Short Ratio | 4.43 X | |||
| Earnings Per Share | (1.15) X | |||
| Number Of Employees | 49 | |||
| Beta | 0.3 | |||
| Market Capitalization | 60.46 M | |||
| Total Asset | 11.75 M | |||
| Retained Earnings | (107.35 M) | |||
| Working Capital | 6.77 M | |||
| Current Asset | 11.27 M | |||
| Current Liabilities | 4.5 M | |||
| Z Score | -0.6 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Heat Stock
If you are still planning to invest in Heat Biologics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Heat Biologics' history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |